Adaptive Biotechnologies Corporation
ADPT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $94 | $59 | $52 | $47 |
| % Growth | 59.6% | 12.3% | 10.5% | – |
| Cost of Goods Sold | $18 | $18 | $17 | $18 |
| Gross Profit | $76 | $41 | $35 | $29 |
| % Margin | 80.7% | 69.4% | 67.6% | 62% |
| R&D Expenses | $24 | $24 | $24 | $23 |
| G&A Expenses | $18 | $18 | $17 | $18 |
| SG&A Expenses | $41 | $41 | $40 | $40 |
| Sales & Mktg Exp. | $23 | $24 | $23 | $22 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $66 | $66 | $65 | $63 |
| Operating Income | $10 | -$25 | -$30 | -$34 |
| % Margin | 10.9% | -42.5% | -56.4% | -71.3% |
| Other Income/Exp. Net | -$1 | -$1 | -$0 | $0 |
| Pre-Tax Income | $10 | -$26 | -$30 | -$34 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $10 | -$26 | -$30 | -$34 |
| % Margin | 10.2% | -43.5% | -56.9% | -71% |
| EPS | 0.06 | -0.17 | -0.2 | -0.23 |
| % Growth | 135.3% | 15% | 13% | – |
| EPS Diluted | 0.06 | -0.17 | -0.2 | -0.23 |
| Weighted Avg Shares Out | 152 | 152 | 149 | 147 |
| Weighted Avg Shares Out Dil | 163 | 152 | 149 | 147 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $3 | $3 |
| Interest Expense | $3 | $3 | $3 | $3 |
| Depreciation & Amortization | $4 | $5 | $3 | $4 |
| EBITDA | $17 | -$18 | -$30 | -$26 |
| % Margin | 18% | -30.8% | -56.4% | -55.5% |